Agent-Based AI Systems Proposed for Clinical Pathology Workflows
Researchers from the Department of Pathology at Peking Union Medical College Hospital have published a review examining how…
Multi-source data-driven machine learning improves lung cancer care
Section 1: Background Lung cancer remains one of the malignancies with the highest incidence and mortality worldwide. Clinical…
AI Model Predicts Cancer Mutations from Histopathology Images
Researchers developed an artificial intelligence (AI) model that analyzes routine histopathology images to simultaneously predict cancer subtypes, genetic…
Artificial Intelligence Improves Accuracy, Efficiency in Prostate Biopsy Review
A multi-center study published in Nature Digital Medicine demonstrates that using artificial intelligence to assist pathologists in prostate…
AI Tool Predicts Immunotherapy Outcomes in Rare Cancers: MD Anderson Study
Researchers from The University of Texas MD Anderson Cancer Center have demonstrated that an artificial intelligence (AI)-based analysis…
AI Pathology Platform Expands to More Hospitals for Cancer Diagnostics
Slideflow Labs, an artificial intelligence (AI) pathology company spun out of research conducted at the University of Chicago,…
Proscia Launches AI-Integrated Concentriq Pathology Platform Update
Proscia has launched the fifth generation of its Concentriq platform, integrating artificial intelligence (AI) into the system architecture…
Agilent Partners with OpenAI and BCG to Advance Artificial Intelligence in Lab Workflows
Agilent Technologies Inc announced a collaboration with OpenAI and Boston Consulting Group to accelerate the deployment of artificial…
Myriad Genetics Launches Prolaris® + AI, the First Prostate Cancer Test to Combine Genomics and Digital Pathology Artificial Intelligence (AI)
Myriad Genetics, Inc. New PATHOMIQ AI integration helps clinicians tailor active surveillance with greater confidence SALT LAKE CITY,…
Artificial intelligence-based tool could improve multiple myeloma treatment decisions
An artificial intelligence-based tool may help physicians determine which newly diagnosed multiple myeloma patients are most likely to…
ViewsML Raises $4.9 Million for AI-Based Virtual Tissue Staining
ViewsML, a company developing software for tissue analysis, announced the completion of an oversubscribed $4.9 million seed funding…